Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

In 2014, a joint consensus document dealing with the management of antithrombotic therapy
in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or …

Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

Aims The respective roles of oral anticoagulation or antiplatelet therapy following
transcatheter aortic valve implantation (TAVI) remain debated. ATLANTIS is an international …

Background The effect of single as compared with dual antiplatelet treatment on bleeding
and thromboembolic events after transcatheter aortic-valve implantation (TAVI) in patients …

In patients with manifestations of cardiovascular disease, acetylsalicylic acid (popularly
known as aspirin) has been the mainstay of treatment for decades owing to its capacity to …

Background: It is unknown whether the direct oral anticoagulant edoxaban can reduce
leaflet thrombosis and the accompanying cerebral thromboembolic risk after transcatheter …

Transcatheter aortic valve implantation (TAVI) is effective in older patients with symptomatic
severe aortic stenosis, while the indication has recently broadened to younger patients at …